Healthy
Conditions
Brief summary
A study to compare the pharmacokinetic(s) of K-877 and CSG452 when each drug is administered alone and when both are administered together.
Sponsors
Kowa Research Institute, Inc.
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
Yes
Inclusion criteria
* Subject provides written informed consent before any study-specific evaluation is performed. * Subject is a healthy adult male or female volunteer between the ages of 18 and 45 years, inclusive, at Screening. * Subject has a BMI of 18 to 30 kg/m2, inclusive, at Screening. * Subject meets all other inclusion criteria outlined in the clinical study protocol
Exclusion criteria
* Subject has clinically relevant abnormalities at Screening or at Check-in assessments. * Subject is pregnant or breastfeeding or intends to become pregnant within 30 days after the last dose of study drug. * Subject does not meet any other
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Area under the plasma concentration versus time curve (AUC) | 0 to 24 hours |
Countries
United States
Outcome results
None listed